Dr. Hacksell commented: “I look forward to working with the Glionova team and some of the most experienced investors in the Nordics to develop this ground breaking therapy”. Dr. Uli Hacksell served as Chief Executive Officer of ACADIA Pharmaceuticals from September 2000 to March 2015 and was a member of its Board of Directors.
Medivirs vd får gå - Uli Hacksell ny tf vd. Experterna i Börsmorgonstudion synar läget.
Christina Herder. Fredrik Öberg. Magnus Christensen. Yilmaz Mahshid. Board of Directors.
- Hypokrom mikrocytar anemi
- Restaurang rönnskär
- Är det bara språket som gör att det ibland går långsammare att läsa på ett nytt språk
- Axjo plastic
- Db2 describe table not working
- Konkurser norrbotten
- Anders wiman trafikverket
- Ekonomisk forening likvidation
Affiliation 1 ACADIA Pharmaceuticals Inc., 11085 Torreyana Road, Uli Hacksell, Ph.D. Chairman of the Board Dr. Hacksell serves as Chairman of the Board of Directors, a position he has held since July of 2018. - Uli Hacksell assumed leadership responsibility for Medivir as acting CEO in the fall of 2018 in conjunction with the strengthened focus on clinical cancer projects and a comprehensive restructuring of the company. Uli has invested enormous energy in shaping and developing Medivir into the company it is today. “I am pleased to welcome Nancy as the new CEO of Adhera Therapeutics,” Uli Hacksell, Ph.D., the Chairman of the Board of Directors of Adhera, said.
Uli Hacksell (CEO). Products, Oncological R&D. Revenue, 658 MM SEK (2015). Number of employees. 15. Website, www.medivir.com. Medivir is a Swedish biotech company. Medivir focuses its research focus on oncology and
and Robert C. Moscato to Board of Directors. June 29, 2018 09:15 ET | Source: Marina Biotech, Inc. Marina Biotech, Ali Tabatabaei, Robert E. Davis, Mark R. Brann, Uli Hacksell and Douglas W. Bonhaus. Journal of Pharmacology and Experimental Therapeutics August 2007 2 Apr 2017 Dr. Uli Hacksell's total compensation package for 2016 was valued at $1.7 million , compared to the $1.1 million package received by Cerecor's 20 jun 2001 Möt Uli Hacksell, den förre Astra Draco-chefen och professorn i organisk kemi som en gång drömde om en karriär som sjukhusapotekare.
Uli Hacksell Peter Luthersson Caisa Lycken Christina Mattsson Adam Sabir Maria Strömme Gunnar Svedberg Johan Wall Eva Åkesson Närvarande suppleanter: utan rösträtt Sven Widmalm Närvarande suppleanter: Med rösträtt Anders Malmberg utan rösträtt Fredrik Hultman ToveLeire Företrädare för de anställda: Stefan Djurström Marie Ols
Pressmeddelande: Notice of extraordinary shareholders Hitta rätt Hacksell i Sverige. Se telefonnummer, adress, karta, grannar, jobb mm. Kontakta personen direkt!
See the complete profile on LinkedIn and discover Uli’s connections
Uli Hacksell CERC stock SEC Form 4 insiders trading. Uli has made over 22 trades of the Cerecor Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently Uli bought 20,000 units of CERC stock worth $15,000 on 10 December 2016. Fredrik Lehmann, Erika A Currier, Roger Olsson, Uli Hacksell, Kristina Luthman Bioorganic & medicinal chemistry - 2005-01-01 A biocatalytic route to P-chirogenic compounds by lipase-catalyzed desymmetrization of a prochiral
Uli Hacksell is considered to be independent in relation to the company as well as its senior management and in relation to major shareholders.
Yrsel nar jag ligger ner
Epub 2014 Mar 30.
Uli Hacksell. Född: 1950. Titel: Ledamot sedan 2018. Utbildning: Apotekare och Farm dr.
Sab system group
“I am pleased to welcome Nancy as the new CEO of Adhera Therapeutics,” Uli Hacksell, Ph.D., the Chairman of the Board of Directors of Adhera, said.
Uli Hacksell is Former President/CEO at Medivir AB. See Uli Hacksell's compensation, career history, education, & memberships. 15 Oct 2018 Medivir were sliding this morning on the sudden departure of chief executive Christine Lind, to be replaced by board member Uli Hacksell. 13 Nov 2017 L-R: Erik Walldén, Uli Hacksell. Beactica, a Swedish drug discovery company, announced the completion of its latest financing round and the Uli Hacksell. Corresponding Author. Department Organic Pharmaceutical Chemistry, Uppsala Biomedical Center, Box 574, University of Uppsala, S‐751 23 Uli Hacksell.
Presentation av Medivir (publ). Medivir utvecklar innovativa läkemedel med fokus på cancersjukdomar där de medicinska behoven är stora. Företaget satsar på i
Uli Hacksell har tidigare varit vd för forskningsbolaget Medivir och har under 90-talet innehaft seniora positioner vid Astra, numera Astra Zeneca.
Snittålder 57 år. Uli Alf Hacksell. 70 år. Yilmaz Mahshid. 41 år 2 kopplingar.